ELGX

Endologix Inc Discusses Q4 2013 Results (Webcast)

[at Seeking Alpha] – The following audio is from a conference call that will begin on February 27, 2014 at 17:00 PM ET. The audio will stream live while the call is active, and can be replayed upon its completion. moreView todays social media effects on ELGXView the latest stocks trending across Twitter. Click to view dashboardSee who Endologix is […]

Endologix Reports 25% and 21% Revenue Growth for the Full Year and Fourth Quarter 2013

[GlobeNewswire] – IRVINE, Calif. — Endologix, Inc. , developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three and twelve months ended December 31, 2013. moreView todays social media effects on ELGXView the latest stocks trending across Twitter. Click to view dashboardSee who Endologix is hiring next, click here to view […]

Endologix Announces FDA Approval of First Percutaneous Indication for Endovascular Abdominal Aortic Aneurysm Repair

[at noodls] – IRVINE, Calif., April 16, 2013 (GLOBE NEWSWIRE) — Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has received U.S. Food and … moreView todays social media effects on ELGXView the latest stocks trending across Twitter. Click to view dashboardSee who Endologix is hiring next, click here to view […]

Endologix Board Member Roderick de Greef to Retire; Thomas F. Zenty, III to Stand for Election as Board Member

[at noodls] – IRVINE, Calif., April 15, 2013 (GLOBE NEWSWIRE) — Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that Roderick de Greef will retire … moreView todays social media effects on ELGXView the latest stocks trending across Twitter. Click to view dashboardSee who Endologix is hiring next, click here to view […]

Endologix Announces Presentation of Data From PEVAR Randomized Trial

[at noodls] – IRVINE, Calif., Jan. 28, 2013 (GLOBE NEWSWIRE) — Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that data from the first prospective, … moreView todays social media effects on ELGXView the latest stocks trending across Twitter. Click to view dashboardSee who Endologix is hiring next, click here to view […]

Endologix to Present at the 31st Annual J.P. Morgan Healthcare Conference

[at noodls] – IRVINE, Calif., Jan. 3, 2013 (GLOBE NEWSWIRE) — Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, President and … moreView todays social media effects on ELGXView the latest stocks trending across Twitter. Click to view dashboardSee who Endologix is hiring next, click here to view […]

Endologix Appoints Shelley B. Thunen Chief Financial Officer

[at noodls] – IRVINE, Calif., Jan. 2, 2013 (GLOBE NEWSWIRE) — Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has appointed Shelley B. Thunen … moreView todays social media effects on ELGXView the latest stocks trending across Twitter. Click to view dashboardSee who Endologix is hiring next, click here to view […]